• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT; PERIPHERALLY INSERTED CENTRAL CATHETER (PICC)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT; PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) Back to Search Results
Catalog Number 7957505
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/17/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a picc was inserted (b)(6) and started transfusion.Health professional said it was a little difficult to infuse.The next day, leakage was confirmed at the time of flushing.Leaked out near, vicinity 33cm to 34cm and damaged.There was no reported patient injury.Leakage due to catheter breakage.No further information was provided.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.The device has not been returned to the manufacturer for evaluation.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of a leaking catheter is confirmed and was determined to be use-related.One 5 fr d/l groshong nxt catheter was returned for evaluation.An initial visual observation revealed evidence of clinical use including biological residue on the catheter and needleless injection caps on both luer hubs.A functional test of flushing the catheter with water using a 12ml syringe was performed, and a leak was observed between the 33 cm and 34 cm depth markers.A microscopic observation revealed a split where the leak was found.The split had an uneven shape and smooth fracture surface.The edges appeared to be mostly clean and sharp.These features suggest the catheter was likely damaged by an external source, most likely contact with a hard and/or metallic instrument.This complaint will be recorded for future trending and monitoring purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG NXT
Common Device Name
PERIPHERALLY INSERTED CENTRAL CATHETER (PICC)
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
veronica lee
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key24769033
Report Number3006260740-2026-02255
Device Sequence Number10276240
Product Code LJS
UDI-Device Identifier00801741035449
UDI-Public(01)00801741035449(11)241024(17)260331(10)REJV1633
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K023374
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/19/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2026
Device Catalogue Number7957505
Device Lot NumberREJV1633
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/19/2026
Supplement Date Received by Manufacturer05/19/2026
Initial Report FDA Received Date04/02/2026
Supplement Report FDA Received Date05/22/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/24/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-